CytoDyn Inc. Appoints David Feigal, M.D., as Chief Medical Officer

28-10-2013 Business Wire HealthComments (0)

BiotechnologyCytoDyn

CytoDyn Inc. (“CytoDyn”) (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced the appointment of Dr. David Feigal as the Company’s new Chief Medical Officer. Dr. David Feigal, M.D., spent 12 years with the U.S. Food & Drug Administration (FDA) where he served as Director, Center for Devices & Radiological Health (CDRH), Director, Division of Anti-infective &a

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top